Filter
2725
Filtered Results: 2725
Text search:
regulatory
control
Featured
Recommendations
244
New Publications
712
Language
Document type
No document type
1262
Studies & Reports
501
Guidelines
491
Manuals
188
Strategic & Response Plan
160
Fact sheets
62
Training Material
23
Situation Updates
22
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
120
Kenya
102
India
91
Ethiopia
58
Nigeria
56
Latin America and the Carribbean
53
Western and Central Europe
49
Sierra Leone
48
South Africa
46
Uganda
46
Ghana
44
Liberia
42
Africa
40
Zambia
37
Tanzania
34
Nepal
33
Bangladesh
32
Namibia
31
Myanmar / Burma
28
Ukraine
27
Rwanda
27
Malawi
25
West and Central Africa
24
South–East Asia Region
24
East and Southern Africa
24
Syria
21
Philippines
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Zimbabwe
13
Guinea
13
Cambodia
12
Asia
12
El Salvador
11
Mozambique
11
Eastern Europe and Central Asia
11
Botswana
11
Congo, Democratic Republic of
10
Argentina
10
Eswatini/ Swaziland
10
Western Pacific Region
9
Russia
9
South Sudan
9
Indonesia
9
Senegal
8
Cameroon
7
Brazil
7
Pakistan
7
Chile
6
USA
6
North America
6
Bolivia
6
Yemen
6
Colombia
5
Burkina Faso
5
Haiti
5
Venezuela
5
Spain
5
Moldova
5
Sudan
5
Tajikistan
4
Thailand
4
Albania
4
Jordan
4
Germany
4
Georgia
4
Angola
4
Chad
4
Somalia
4
Ecuador
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea-Bissau
3
United Kingdom
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Gambia
2
Kazakhstan
2
Iran
2
Saudi Arabia
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Honduras
2
Mali
2
Iraq
2
Madagascar
2
Guatemala
2
Turkey
1
Australia
1
Togo
1
China
1
Fiji
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Burundi
1
Morocco
1
Qatar
1
Mauritania
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1022
Clinical Guidelines
192
Public Health
179
Key Resources
148
Women & Child Health
96
Pharmacy & Technologies
73
Capacity Building
25
Toolboxes
COVID-19
273
AMR
176
HIV
168
TB
138
Mental Health
119
Pharmacy
119
Planetary Health
112
Caregiver
91
NTDs
71
Rapid Response
64
NCDs
60
Ebola & Marburg
53
Malaria
52
Global Health Education
46
Conflict
41
Health Financing Toolbox
38
Specific Hazards
35
2.0 Rapid Response
34
Disability
31
Refugee
29
Natural Hazards
21
Zika
21
Polio
17
Cholera
11
Social Ethics
9
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys...
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its objectives are to minimize...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
This report challenges policy-makers and political leaders to tackle fossil fuel production and consumption as a health control issue, in the same way that smoking has been reduced and regulated. Fossil fuel combustion is a major source of toxic air pollution that kills 7 million people every year, ...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
